Ausgabe 7/2010
Inhalt (15 Artikel)
Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies
Ulrike Bacher, Claudia Haferlach, Susanne Schnittger, Alexander Kohlmann, Wolfgang Kern, Torsten Haferlach
Mechanisms of resistance against PKC412 in resistant FLT3-ITD positive human acute myeloid leukemia cells
Friedrich Stölzel, Christine Steudel, Uta Oelschlägel, Brigitte Mohr, Sina Koch, Gerhard Ehninger, Christian Thiede
Expression of pSTAT5 predicts FLT3 internal tandem duplications in acute myeloid leukemia
Ellen Christina Obermann, Caroline Arber, Martine Jotterand, Andre Tichelli, Petra Hirschmann, Alexandar Tzankov
Mean corpuscular volume predicts prognosis in MDS patients with abnormal karyotypes
Hong Wang, XiaoQin Wang, XiaoPing Xu, GuoWei Lin
Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment
Joon Ho Moon, Shi Nae Kim, Byung Woog Kang, Yee Soo Chae, Jong Gwang Kim, Jin Ho Baek, Jae Hoo Park, Moo Kon Song, Joo Seop Chung, Jong Ho Won, Sang Min Lee, Young Don Joo, Yeo Kyeoung Kim, Hyeong Joon Kim, Deog Yeon Jo, Sang Kyun Sohn
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs
Elena Crisà, Ermanno Venturino, Roberto Passera, Marco Prina, Piercarla Schinco, Alessandra Borchiellini, Valentina Giai, Maria Ausilia Ciocca Vasino, Mario Bazzan, Antonella Vaccarino, Mario Boccadoro, Dario Ferrero
Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy
Kevin Kemp, Ruth Morse, Sarah Wexler, Christine Cox, Elizabeth Mallam, Jill Hows, Craig Donaldson
Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia
Yu-Hua Chao, Ching-Tien Peng, Horng-Jyh Harn, Chin-Kan Chan, Kang-Hsi Wu
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib
Youngil Koh, Inho Kim, Sung-Soo Yoon, Byoung Kook Kim, Dae-Young Kim, Je-Hwan Lee, Kyoo-Hyung Lee, Eunkyung Park, Hyeoung-Joon Kim, Sang Kyun Sohn, Young Don Joo, Seok Jin Kim, Jooseop Chung, Ho-Jin Shin, Sung-Hyun Kim, Chul Soo Kim, Hong Suk Song, Min Kyoung Kim, Myung Soo Hyun, Jin Seok Ahn, Chul Won Jung, Seonyang Park
Idiopathic neutropenia with fewer than 5% dysplasia may be a distinct entity of idiopathic cytopenia of undetermined significance
Keiko Ando, Atsushi Kodama, Tamiko Iwabuchi, Junko H. Ohyashiki, Kazuma Ohyashiki
Resolution of invasive fungal sinusitis in immunocompromised patients: neutrophil count is crucial beside a combined medical and surgical approach
Patrizia Zappasodi, Marianna Rossi, Carlo Castagnola, Fabio Pagella, Elina Matti, Caterina Cavanna, Alessandro Corso, Maurizio Bonfichi, Mario Lazzarino
Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia
Sumimasa Nagai, Yasuhito Nannya, Tsuyoshi Takahashi, Mineo Kurokawa
Acquired erythropoietic protoporphyria
Daniel Blagojevic, Thomas Schenk, Oskar Haas, Brigitte Zierhofer, Christophoros Konnaris, Franz Trautinger
Imatinib and cardiac failure in idiopathic hypereosinophilic syndrome
Lisa Pieri, Alberto Bosi, Alessandro M. Vannucchi
ABO discrepancy in an elderly patient with IgA kappa-type multiple myeloma
So Young Kim, Seung Hwan Oh, Kyung Sun Park, Min Jin Kim, Gayoung Lim, Sun Young Cho, Hee Joo Lee, Jin-Tae Suh, Hwi-Joong Yoon, Tae Sung Park